Glycopeptide-Intermediate Staphylococcus aureus: Evaluation of a Novel Screening Method and Results of a Survey of Selected U.S. Hospitals

Isolates of Staphylococcus aureus with decreased susceptibilities to glycopeptide antimicrobial agents, such as vancomycin and teicoplanin, have emerged in the United States and elsewhere. Commercially prepared brain heart infusion agar (BHIA) supplemented with 6 μg of vancomycin per ml was shown in...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	J Clin Microbiol
Asıl Yazarlar:	Hubert, Susannah K., Mohammed, Jasmine M., Fridkin, Scott K., Gaynes, Robert P., McGowan, John E., Tenover, Fred C.
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1999
Konular:	Bacteriology
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC85700/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10523558/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.37.11.3590-3593.1999
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!